BlackRock Capital Allocation Term Trust
BCAT
$15.90
$0.161.02%
| Weiss Ratings | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | BlackRock | |||
| Manager/Tenure (Years) | David Clayton (5), Russ Koesterich (5), Rick Rieder (5) | |||
| Website | http://www.blackrock.com | |||
| Fund Information | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | BlackRock Capital Allocation Term Trust | |||
| Category | Tactical Allocation | |||
| Sub-Category | Flexible Allocation | |||
| Prospectus Objective | Income | |||
| Inception Date | Sep 28, 2020 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 2.04% | |||
| Dividend | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.30% | |||
| Asset Allocation | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | -95.37% | |||
| Stock | 46.87% | |||
| U.S. Stock | 32.20% | |||
| Non-U.S. Stock | 14.67% | |||
| Bond | 64.66% | |||
| U.S. Bond | 51.48% | |||
| Non-U.S. Bond | 13.18% | |||
| Preferred | 4.19% | |||
| Convertible | 0.88% | |||
| Other Net | 78.78% | |||
| Price History | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.15% | |||
| 30-Day Total Return | 2.36% | |||
| 60-Day Total Return | 0.88% | |||
| 90-Day Total Return | 3.52% | |||
| Year to Date Total Return | 9.53% | |||
| 1-Year Total Return | 17.33% | |||
| 2-Year Total Return | 27.64% | |||
| 3-Year Total Return | 47.21% | |||
| 5-Year Total Return | 34.33% | |||
| Price | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | $15.31 | |||
| 1-Month High Price | $16.19 | |||
| 52-Week Low Price | $13.84 | |||
| 52-Week Low Price (Date) | Nov 20, 2025 | |||
| 52-Week High Price | $16.19 | |||
| 52-Week High Price (Date) | Aug 13, 2026 | |||
| NAV | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $14.30 | |||
| 1-Month Low NAV | $14.07 | |||
| 1-Month High NAV | $14.75 | |||
| 52-Week Low NAV | $14.01 | |||
| 52-Week Low NAV (Date) | Mar 30, 2026 | |||
| 52-Week High NAV | $15.74 | |||
| 52-Week High Price (Date) | Sep 11, 2025 | |||
| Beta / Standard Deviation | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Standard Deviation | 8.02 | |||
| Balance Sheet | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.50B | |||
| Operating Ratios | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.99% | |||
| Turnover Ratio | 260.00% | |||
| Performance | BCAT-NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 18.50% | |||
| Last Bear Market Total Return | -8.50% | |||